Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1479-5876-10-1.

Title:
The immune score as a new possible approach for the classification of cancer | Journal of Translational Medicine
Description:
The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N), and evidence for metastases (M). However, this classification provides limited prognostic information in estimating the outcome in cancer and does not predict response to therapy. It is recognized that cancer outcomes can vary significantly among patients within the same stage. Recently, many reports suggest that cancer development is controlled by the host
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, immune, tumor, pubmed, article, google, scholar, prognostic, clinical, classification, tumors, immunotherapy, galon, cells, patients, immunology, cell, cas, score, outcome, human, melanoma, colorectal, memory, data, research, usa, markers, central, cancers, national, center, approach, access, development, prognosis, assay, med, paris, open, jérôme, fox, staging, factor, society, microenvironment, meeting, mlecnik, pages, including,

Topics {✒️}

anti-tumour vaccines article download pdf isbtc-sitc/fda/nci workshop long-lasting antitumor capacity improve clinical decision-making ajcc/uicc-tnm classification ajcc/uicc tnm-classification franck pagès histopathologic-based prognostic factors predictive markers privacy choices/manage cookies open access call open access forum isbtc-fda taskforce open access manuscript jérôme galon cross-laboratory assay validation early-stage colorectal cancer article galon strongest prognostic factor traditional staging system recently genetic markers ascierto pa immunological molecular markers stimulate international collaborations butterfield lh december 6th-7th 2010 la fondazione melanoma reach clinical applicability chiles research institute distinct underlying biology limited prognostic information regional lymph nodes region selection criteria lymphoid islets adjacent probable universal character current immunohistochemical technologies dieu-nosjean mc innovative therapies unit important clinical translation biomed central atypical cell morphology squamous cell carcinoma worldwide voluntary participation conditions privacy policy essential prognostic factor immune system underlying innate immune activation immune pattern remained local immune reaction

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The immune score as a new possible approach for the classification of cancer
         description:The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N), and evidence for metastases (M). However, this classification provides limited prognostic information in estimating the outcome in cancer and does not predict response to therapy. It is recognized that cancer outcomes can vary significantly among patients within the same stage. Recently, many reports suggest that cancer development is controlled by the host's immune system underlying the importance of including immunological biomarkers for the prediction of prognosis and response to therapy. Data collected from large cohorts of human cancers demonstrated that the immune-classification has a prognostic value that may be superior to the AJCC/UICC TNM-classification. Thus, it is imperative to begin incorporating immune scoring as a prognostic factor and to introduce this parameter as a marker to classify cancers, as part of the routine diagnostic and prognostic assessment of tumors. At the same time, the inherent complexity of quantitative immunohistochemistry, in conjunction with variable assay protocols across laboratories, the different immune cell types analyzed, different region selection criteria, and variable ways to quantify immune infiltration underscore the urgent need to reach assay harmonization. In an effort to promote the immunoscore in routine clinical settings worldwide, the Society for Immunotherapy of Cancer (SITC), the European Academy of Tumor Immunology, the Cancer and Inflammation Program, the National Cancer Institute, National Institutes of Health, USA and "La Fondazione Melanoma" will jointly initiate a task force on Immunoscoring as a New Possible Approach for the Classification of Cancer that will take place in Naples, Italy, February 13th, 2012. The expected outcome will include a concept manuscript that will be distributed to all interested participants for their contribution before publication outlining the goal and strategy to achieve this effort; a preliminary summary to be presented during the "Workshop on Tumor Microenvironment" prior to the SITC annual meeting on October 24th - 25th 2012 in Bethesda, Maryland, USA and finally a "Workshop on Immune Scoring" to be held in Naples in December of 2012 leading to the preparation of a summary document providing recommendations for the harmonization and implementation of the Immune Score as a new component for the classification of cancer.
         datePublished:2012-01-03T00:00:00Z
         dateModified:2012-01-03T00:00:00Z
         pageStart:1
         pageEnd:4
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1479-5876-10-1
         keywords:
            Biomedicine
            general
            Medicine/Public Health
         image:
         isPartOf:
            name:Journal of Translational Medicine
            issn:
               1479-5876
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jérôme Galon
               affiliation:
                     name:Laboratory of Integrative Cancer Immunology
                     address:
                        name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Université Paris Descartes
                     address:
                        name:Université Paris Descartes, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Université Pierre et Marie Curie Paris 6
                     address:
                        name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:HEGP
                     address:
                        name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Milwaukee
                     address:
                        name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Franck Pagès
               affiliation:
                     name:Laboratory of Integrative Cancer Immunology
                     address:
                        name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Université Paris Descartes
                     address:
                        name:Université Paris Descartes, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:Université Pierre et Marie Curie Paris 6
                     address:
                        name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
                        type:PostalAddress
                     type:Organization
                     name:HEGP
                     address:
                        name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francesco M Marincola
               affiliation:
                     name:Milwaukee
                     address:
                        name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                        type:PostalAddress
                     type:Organization
                     name:National Institutes of Health
                     address:
                        name:Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Magdalena Thurin
               affiliation:
                     name:National Institutes of Health (NIH)
                     address:
                        name:Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giorgio Trinchieri
               affiliation:
                     name:National Institutes of Health
                     address:
                        name:Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bernard A Fox
               affiliation:
                     name:Milwaukee
                     address:
                        name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                        type:PostalAddress
                     type:Organization
                     name:Providence Portland Medical Center
                     address:
                        name:Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
                        type:PostalAddress
                     type:Organization
                     name:Oregon Health and Science University
                     address:
                        name:Department of Molecular Microbiology and Immunology, Oregon Health and Science University, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas F Gajewski
               affiliation:
                     name:Milwaukee
                     address:
                        name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                        type:PostalAddress
                     type:Organization
                     name:the University of Chicago
                     address:
                        name:Department of Pathology and Department of Medicine, Section of Hematology/Oncology, the University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paolo A Ascierto
               affiliation:
                     name:Fondazione "G. Pascale"
                     address:
                        name:Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale", Napoli, Italy
                        type:PostalAddress
                     type:Organization
                     name:Fondazione Melanoma Onlus Via Mariano Semmola
                     address:
                        name:Fondazione Melanoma Onlus Via Mariano Semmola, Napoli, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The immune score as a new possible approach for the classification of cancer
      description:The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N), and evidence for metastases (M). However, this classification provides limited prognostic information in estimating the outcome in cancer and does not predict response to therapy. It is recognized that cancer outcomes can vary significantly among patients within the same stage. Recently, many reports suggest that cancer development is controlled by the host's immune system underlying the importance of including immunological biomarkers for the prediction of prognosis and response to therapy. Data collected from large cohorts of human cancers demonstrated that the immune-classification has a prognostic value that may be superior to the AJCC/UICC TNM-classification. Thus, it is imperative to begin incorporating immune scoring as a prognostic factor and to introduce this parameter as a marker to classify cancers, as part of the routine diagnostic and prognostic assessment of tumors. At the same time, the inherent complexity of quantitative immunohistochemistry, in conjunction with variable assay protocols across laboratories, the different immune cell types analyzed, different region selection criteria, and variable ways to quantify immune infiltration underscore the urgent need to reach assay harmonization. In an effort to promote the immunoscore in routine clinical settings worldwide, the Society for Immunotherapy of Cancer (SITC), the European Academy of Tumor Immunology, the Cancer and Inflammation Program, the National Cancer Institute, National Institutes of Health, USA and "La Fondazione Melanoma" will jointly initiate a task force on Immunoscoring as a New Possible Approach for the Classification of Cancer that will take place in Naples, Italy, February 13th, 2012. The expected outcome will include a concept manuscript that will be distributed to all interested participants for their contribution before publication outlining the goal and strategy to achieve this effort; a preliminary summary to be presented during the "Workshop on Tumor Microenvironment" prior to the SITC annual meeting on October 24th - 25th 2012 in Bethesda, Maryland, USA and finally a "Workshop on Immune Scoring" to be held in Naples in December of 2012 leading to the preparation of a summary document providing recommendations for the harmonization and implementation of the Immune Score as a new component for the classification of cancer.
      datePublished:2012-01-03T00:00:00Z
      dateModified:2012-01-03T00:00:00Z
      pageStart:1
      pageEnd:4
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1479-5876-10-1
      keywords:
         Biomedicine
         general
         Medicine/Public Health
      image:
      isPartOf:
         name:Journal of Translational Medicine
         issn:
            1479-5876
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jérôme Galon
            affiliation:
                  name:Laboratory of Integrative Cancer Immunology
                  address:
                     name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Université Paris Descartes
                  address:
                     name:Université Paris Descartes, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Université Pierre et Marie Curie Paris 6
                  address:
                     name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:HEGP
                  address:
                     name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Milwaukee
                  address:
                     name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Franck Pagès
            affiliation:
                  name:Laboratory of Integrative Cancer Immunology
                  address:
                     name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Université Paris Descartes
                  address:
                     name:Université Paris Descartes, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:Université Pierre et Marie Curie Paris 6
                  address:
                     name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
                     type:PostalAddress
                  type:Organization
                  name:HEGP
                  address:
                     name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francesco M Marincola
            affiliation:
                  name:Milwaukee
                  address:
                     name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                     type:PostalAddress
                  type:Organization
                  name:National Institutes of Health
                  address:
                     name:Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Magdalena Thurin
            affiliation:
                  name:National Institutes of Health (NIH)
                  address:
                     name:Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giorgio Trinchieri
            affiliation:
                  name:National Institutes of Health
                  address:
                     name:Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bernard A Fox
            affiliation:
                  name:Milwaukee
                  address:
                     name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                     type:PostalAddress
                  type:Organization
                  name:Providence Portland Medical Center
                  address:
                     name:Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
                     type:PostalAddress
                  type:Organization
                  name:Oregon Health and Science University
                  address:
                     name:Department of Molecular Microbiology and Immunology, Oregon Health and Science University, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas F Gajewski
            affiliation:
                  name:Milwaukee
                  address:
                     name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
                     type:PostalAddress
                  type:Organization
                  name:the University of Chicago
                  address:
                     name:Department of Pathology and Department of Medicine, Section of Hematology/Oncology, the University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paolo A Ascierto
            affiliation:
                  name:Fondazione "G. Pascale"
                  address:
                     name:Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale", Napoli, Italy
                     type:PostalAddress
                  type:Organization
                  name:Fondazione Melanoma Onlus Via Mariano Semmola
                  address:
                     name:Fondazione Melanoma Onlus Via Mariano Semmola, Napoli, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Translational Medicine
      issn:
         1479-5876
      volumeNumber:10
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Laboratory of Integrative Cancer Immunology
      address:
         name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
         type:PostalAddress
      name:Université Paris Descartes
      address:
         name:Université Paris Descartes, Paris, France
         type:PostalAddress
      name:Université Pierre et Marie Curie Paris 6
      address:
         name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
         type:PostalAddress
      name:HEGP
      address:
         name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
         type:PostalAddress
      name:Milwaukee
      address:
         name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
         type:PostalAddress
      name:Laboratory of Integrative Cancer Immunology
      address:
         name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
         type:PostalAddress
      name:Université Paris Descartes
      address:
         name:Université Paris Descartes, Paris, France
         type:PostalAddress
      name:Université Pierre et Marie Curie Paris 6
      address:
         name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
         type:PostalAddress
      name:HEGP
      address:
         name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
         type:PostalAddress
      name:Milwaukee
      address:
         name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
         type:PostalAddress
      name:National Institutes of Health
      address:
         name:Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, USA
         type:PostalAddress
      name:National Institutes of Health (NIH)
      address:
         name:Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, USA
         type:PostalAddress
      name:National Institutes of Health
      address:
         name:Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA
         type:PostalAddress
      name:Milwaukee
      address:
         name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
         type:PostalAddress
      name:Providence Portland Medical Center
      address:
         name:Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
         type:PostalAddress
      name:Oregon Health and Science University
      address:
         name:Department of Molecular Microbiology and Immunology, Oregon Health and Science University, USA
         type:PostalAddress
      name:Milwaukee
      address:
         name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
         type:PostalAddress
      name:the University of Chicago
      address:
         name:Department of Pathology and Department of Medicine, Section of Hematology/Oncology, the University of Chicago, Chicago, USA
         type:PostalAddress
      name:Fondazione "G. Pascale"
      address:
         name:Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale", Napoli, Italy
         type:PostalAddress
      name:Fondazione Melanoma Onlus Via Mariano Semmola
      address:
         name:Fondazione Melanoma Onlus Via Mariano Semmola, Napoli, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jérôme Galon
      affiliation:
            name:Laboratory of Integrative Cancer Immunology
            address:
               name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
               type:PostalAddress
            type:Organization
            name:Université Paris Descartes
            address:
               name:Université Paris Descartes, Paris, France
               type:PostalAddress
            type:Organization
            name:Université Pierre et Marie Curie Paris 6
            address:
               name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
               type:PostalAddress
            type:Organization
            name:HEGP
            address:
               name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
               type:PostalAddress
            type:Organization
            name:Milwaukee
            address:
               name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Franck Pagès
      affiliation:
            name:Laboratory of Integrative Cancer Immunology
            address:
               name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
               type:PostalAddress
            type:Organization
            name:Université Paris Descartes
            address:
               name:Université Paris Descartes, Paris, France
               type:PostalAddress
            type:Organization
            name:Université Pierre et Marie Curie Paris 6
            address:
               name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
               type:PostalAddress
            type:Organization
            name:HEGP
            address:
               name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
               type:PostalAddress
            type:Organization
      name:Francesco M Marincola
      affiliation:
            name:Milwaukee
            address:
               name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
               type:PostalAddress
            type:Organization
            name:National Institutes of Health
            address:
               name:Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, USA
               type:PostalAddress
            type:Organization
      name:Magdalena Thurin
      affiliation:
            name:National Institutes of Health (NIH)
            address:
               name:Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, USA
               type:PostalAddress
            type:Organization
      name:Giorgio Trinchieri
      affiliation:
            name:National Institutes of Health
            address:
               name:Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA
               type:PostalAddress
            type:Organization
      name:Bernard A Fox
      affiliation:
            name:Milwaukee
            address:
               name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
               type:PostalAddress
            type:Organization
            name:Providence Portland Medical Center
            address:
               name:Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
               type:PostalAddress
            type:Organization
            name:Oregon Health and Science University
            address:
               name:Department of Molecular Microbiology and Immunology, Oregon Health and Science University, USA
               type:PostalAddress
            type:Organization
      name:Thomas F Gajewski
      affiliation:
            name:Milwaukee
            address:
               name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
               type:PostalAddress
            type:Organization
            name:the University of Chicago
            address:
               name:Department of Pathology and Department of Medicine, Section of Hematology/Oncology, the University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Paolo A Ascierto
      affiliation:
            name:Fondazione "G. Pascale"
            address:
               name:Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale", Napoli, Italy
               type:PostalAddress
            type:Organization
            name:Fondazione Melanoma Onlus Via Mariano Semmola
            address:
               name:Fondazione Melanoma Onlus Via Mariano Semmola, Napoli, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
      name:Université Paris Descartes, Paris, France
      name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
      name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
      name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
      name:INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France
      name:Université Paris Descartes, Paris, France
      name:Centre de Recherche des Cordeliers, Université Pierre et Marie Curie Paris 6, Paris, France
      name:Assistance Publique-Hopitaux de Paris, HEGP, Paris, France
      name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
      name:Infectious Disease and Immunogenetics Section (IDIS), Clinical Center and trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, USA
      name:Cancer Diagnosis Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, Maryland, USA
      name:Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA
      name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
      name:Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
      name:Department of Molecular Microbiology and Immunology, Oregon Health and Science University, USA
      name:Society for ImmunoTherapy of Cancer, Milwaukee, Milwaukee, USA
      name:Department of Pathology and Department of Medicine, Section of Hematology/Oncology, the University of Chicago, Chicago, USA
      name:Medical Oncology and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale", Napoli, Italy
      name:Fondazione Melanoma Onlus Via Mariano Semmola, Napoli, Italy

External Links {🔗}(106)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.59s.